Details for New Drug Application (NDA): 020214
✉ Email this page to a colleague
The generic ingredient in ZEMURON is rocuronium bromide. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.
Summary for 020214
| Tradename: | ZEMURON |
| Applicant: | Organon Usa Inc |
| Ingredient: | rocuronium bromide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Mar 17, 1994 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Mar 17, 1994 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/10ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Mar 17, 1994 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 020214
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-001 | Mar 17, 1994 | ⤷ Get Started Free | ⤷ Get Started Free |
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-003 | Mar 17, 1994 | ⤷ Get Started Free | ⤷ Get Started Free |
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-002 | Mar 17, 1994 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
